Drugs / Polio Sabin™ Mono Two
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02582255 | Nov 2015 → Jul 2016 | poliomyelitis | Fidec Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polio Sabin Mono Two | “Polio Sabin™ Mono Two (oral) is a licensed, monovalent, live attenuated poliomyelitis virus vaccine of the Sabin strain Type 2 (P 712, Ch, 2ab), propagated in MRC5 human diploid cells.” NCT02582255 ↗ |
| Modality | Vaccine | “Polio Sabin™ Mono Two (oral) is a licensed, monovalent, live attenuated poliomyelitis virus vaccine” NCT02582255 ↗ |
| Route | Oral | “Polio Sabin™ Mono Two (oral)” NCT02582255 ↗ |